New CPT Code May Lead to Wider Use of AI Technology for Quantifying Coronary Artery Calcium on Chest CT
Code for quantitative CT tissue characterization goes into effect on July 1.
The American Medical Association (AMA) has reportedly issued a new Category III Current Procedural Terminology (CPT) code that radiologists and other clinicians may employ for quantitative CT tissue characterization, according to Nanox and Nanox.AI.
The companies said this code (going into effect on July 1) may provide a pathway for broader use of their artificial intelligence (AI)-enabled HealthCCSng, a cardiac imaging modality which radiologists may use adjunctively with chest computed tomography (CT) to help quantify coronary artery calcium (CAC), a key biomarker of cardiovascular disease.
While assessing CAC with chest CT alone can be a time-consuming endeavor, Nanox noted the FDA-cleared HealthCCSng facilitates efficient analysis of non-gated CT scans, quantifies the amount of CAC and subsequently provides risk stratification for patients into three categories based on the CAC detected.
“AI-enabled technologies that are built into existing radiologist workflows can help them identify at-risk patients and provide enhanced clinical insights,” said Erez Meltzer, the chief executive officer for Nanox. “We believe this (CPT code) is an important milestone that will enable radiologists and physicians in the United States to provide their patients with better care and a promising step toward realizing … the growing importance of AI-based imaging technologies in value-based care.”
Study: AI-Generated ADC Maps from MRI More Than Double Specificity in Prostate Cancer Detection
June 5th 2025Emerging research showed that AI-generated ADC mapping from MRI led to significant increases in accuracy, PPV and specificity in comparison to conventional ADC mapping while achieving a 93 percent sensitivity for PCa.
Can AI Assessment of PET Imaging Predict Treatment Outcomes for Patients with Lymphoma?
June 2nd 2025The use of adjunctive AI software with pre-treatment PET imaging demonstrated over a fourfold higher likelihood of predicting progression-free survival (PFS) in patients being treated for lymphoma, according to a new meta-analysis.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
